This trial will test if regular exercise may help improve how well the brain regulates blood flow in CKD patients.
- Chronic Kidney Disease
2 Primary · 0 Secondary · Reporting Duration: cerebrovascular carbon dioxide reactivity will be compared at baseline (week 0) and after completing the 12-week intervention (week 13).
2 Treatment Groups
1 of 2
1 of 2
48 Total Participants · 2 Treatment Groups
Primary Treatment: Exercise Training · Has Placebo Group · N/A
Who is running the clinical trial?
Age 30 - 75 · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Who else is applying?
What state do they live in?
How old are they?
|18 - 65||100.0%|
What portion of applicants met pre-screening criteria?
|Did not meet criteria||100.0%|
Frequently Asked Questions
Am I able to register for this clinical trial?
"This research trial has a limited capacity of 48, who must be between 30 and 75 years old and have advanced stages (III-IV) of chronic kidney disease." - Anonymous Online Contributor
Do elderly individuals qualify to participate in this trial?
"The age range for inclusion in this trial has been specified as between 30 and 75 years old. Alternatively, there are other trials available to individuals below 18 years of age (43) and those above 65 (458)." - Anonymous Online Contributor
Are there any opportunities to enroll in this trial presently?
"Affirmative. According to clinicaltrials.gov, this trial which was first advertised on August 1st 2022 is still open for recruitment. The most up-to-date information indicates that 48 patients are needed at a single location." - Anonymous Online Contributor
What is the current enrollment quota for this research experiment?
"Affirmative. Clinicaltrials.gov records show that this trial was first advertised on August 1st, 2022 and is still actively recruiting candidates as of October 4th, 2022. The study seeks 48 volunteers from a single site." - Anonymous Online Contributor